Spinal Muscular Atrophy Type INCT05878418
The Effect of Spinal Orthosis on the Development of Scoliosis and Chest Deformity in Type I Spinal Muscular Atrophy
A study testing Thoracolumbosacral Spinal Orthosis (TLSO) and Trunk Exercise (TE), Pulmonary Rehabilitation(PR) and Pulmonary Care (PC) in people with Spinal Muscular Atrophy Type I and Scoliosis, run by Medipol University at 1 site in Turkey (Türkiye).
Trial summary
Spinal muscular atrophy (SMA) is a serious neuromuscular disease characterized by the degeneration of alpha motor neurons in the spinal cord, resulting in progressive proximal muscle atrophy and denervation. Read more about this study
- Who is it for?
- Ages 2 to 6 yearsHealthy volunteers can take part
- Conditions the study is for
- Spinal Muscular Atrophy Type I, Scoliosis, Chest Deformities
- What is being tested?
- Thoracolumbosacral Spinal Orthosis (TLSO) and Trunk Exercise (TE), Pulmonary Rehabilitation(PR) and Pulmonary Care (PC)
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 11 Oct 2023to 10 Sep 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 2 to 6 years
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- 2-6 years old,
- Clinically and genetically diagnosed as Type I SMA,
- Having scoliosis (20-40 Cobb angle),
- Children who have not had any previous spinal surgery,
- Children who have received or continue to receive their medical treatments (nusinersen and onasemnogene abeparvovec).
Who cannot join
- Having acute respiratory failure and/or serious airway infections,
- 24-hour mechanical ventilation dependency,
- Continuing medical treatment in intensive care,
- Having other orthopedic and neurological problems,
- Children of parents who did not agree to participate in the study,
- Children whose chest expansion and/or oxygenation are at risk of being affected and who cannot tolerate the orthosis,
- Children and their parents who do not use the thoracolumbosacral spinal orthosis in accordance with the study protocol and do not comply with trunk exercises, pulmonary rehabilitation and pulmonary care practices.
Trial locations and contacts
1 site in 1 country.
About this study
Spinal muscular atrophy (SMA) is a serious neuromuscular disease characterized by the degeneration of alpha motor neurons in the spinal cord, resulting in progressive proximal muscle atrophy and denervation. The main problems are posture disorders, scoliosis, pelvic curvature, contracture, hip dislocation, foot and chest deformities. In this study, examining the effectiveness of trunk support used to alleviate the progression of scoliosis in children diagnosed with SMA Type I will contribute to the current literature.In addition to Individualized Trunk Exercises (ITE), Individualized Pulmonary Rehabilitation (IPR) and Chest Care (CC) Programme, the use of thoracolumbosacral spinal orthosis in Type I children will be used for the first time in our country and in the world literature. SMA. Our aim in the project is to examine the effectiveness of this treatment program on the motor functions, scoliosis Cobb angle, pelvic curvature and chest deformity of children with Type I SMA.The project is planned to be carried out with children diagnosed with Type I SMA who are followed up at Medipol Mega University Hospital Pediatric Chest Diseases Polyclinic.In evaluating the development of scoliosis as the primary outcome measure; Radiological evaluation (Cobb Angle) and examination of chest deformity; Lung X-ray (Basal Chest Wall Upper-Lower Ratio Measurement) will be used. As secondary outcome measures, the Children's Hospital of Philadelphia Infant Test for Neuromuscular Disorders and the Hammersmith Functional Motor Scale Expanded were used to assess motor functions and examine the level of motor development; In the World Health Organization Motor Development Scale body posture assessment; Supine Trunk Rotation Angle Test and Pelvic Curvature Test, pulse oximetry to assess oxygenation; In determining the level of satisfaction with orthosis use; Children/families' information will be questioned through the Quebec Assistive Technology User Satisfaction Evaluation Survey and Personal Information Form.The active control group will receive the ITE, IPR and CC program as a home program and once a week in the outpatient clinic for 8 weeks, 7 days a week, once a day, each session being 50-60 minutes. In the ITE-IPR-CC + spine orthosis group, in addition to the control group program, a thoracolumbosacral spine orthosis specially designed for the child will be used every day of the week and 8 hours a day for 8 weeks. Evaluations will be made at baseline and at week 8.
Read the detailed description
With the increase in scoliosis and scoliosis-related symptoms after increased survival in patients with Type I SMA, the need for physiotherapy applications has become more important than ever (Trenkle, et al., 2021; Mercuri, et al., 2018). The presence of scoliosis significantly affects lung capacity, postural control, functionality and quality of life in patients with Type I SMA. For this reason, it is of great importance to treat these patients in a timely and effective manner. There is no consensus on the type of spinal orthosis and application protocol to be used in patients with SMA (Mercuri, et al., 2018). When the literature was examined, no study was found about the effect of spinal orthosis use on scoliosis and chest deformity in Type I SMA patients.
- Conditions
- Spinal Muscular Atrophy Type I, Scoliosis, Chest Deformities, Spinal Orthosis, Pulmonary Rehabilitation, Exercise
- Being tested
- Thoracolumbosacral Spinal Orthosis (TLSO), Trunk Exercise (TE), Pulmonary Rehabilitation(PR) and Pulmonary Care (PC)
- Keywords
- Spinal Muscular Atrophy Type I, Scoliosis, Chest Deformities, Spinal Orthosis, Pulmonary Rehabilitation, Exercise
- Medical subject headings
- Spinal Muscular Atrophies of Childhood, Scoliosis, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Thoracolumbosacral Spinal Orthosis (TLSO)Device
Also called Pulmonary Rehabilitation, Pulmonary Care, Trunk Exercise
In the TE, PR, PC + spinal orthosis group, in addition to the control group program, a thoracolumbosacral spinal orthosis (TLSO) designed specifically for the child will be used for 8 hours a day for 8 weeks, every day of the week.
Trunk Exercise (TE), Pulmonary Rehabilitation(PR) and Pulmonary Care (PC)Other
The active control group will receive a TE, PR and PC program in the outpatient clinic once a week for 8 weeks, 7 days a week, once a day, 50-60 minutes per session, for 8 weeks.
| Study group | Role | What they receive |
|---|---|---|
| Trunk Exercises, Pulmonary Rehabilitation and Pulmonary Care Program + Spinal Orthosis Group | Experimental | Trunk Exercises, Pulmonary Rehabilitation and Pulmonary Care Program + Toracolumbosacral Spinal Orthosis Receives: Device: Thoracolumbosacral Spinal Orthosis (TLSO); Other: Trunk Exercise (TE), Pulmonary Rehabilitation(PR) and Pulmonary Care (PC) |
| Trunk Exercises, Pulmonary Rehabilitation and Pulmonary Care Program Group | Active comparator | Trunk Exercises, Pulmonary Rehabilitation and Pulmonary Care Program Receives: Other: Trunk Exercise (TE), Pulmonary Rehabilitation(PR) and Pulmonary Care (PC) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Radiological Evaluation (Cobb Angle)
The presence of scoliosis will initially be evaluated clinically using spinal x-rays. The Cobb angle will be used as a measure of scoliosis progression. If possible, radiological evaluation will be performed in the assisted sitting position without providing sitting balance, if it is difficult to take X-rays in the sitting position, in the supine position. Two images will be obtained, anteroposterior and lateral. The location of scoliosis will be classified as thoracic, thoracolumbar and lumbar. Scoliosis direction will be recorded as right and left. In the case of S-shaped scoliosis, the angle used for assessment will be the highest degree.
Measured: 8 week
Lung X-ray (Basal Chest Wall Upper-Lower Ratio Measurement)
The anteroposterior view of the chest radiograph taken in the supine position will be used. A perpendicular line will be drawn connecting the spinous processes to the horizontal lines drawn from the inner edge of the rib. The longest line of the 2nd rib (Dapex(upper)) and the 9th rib (Dbase(lower)) will be measured. The percentage ratio of the upper/lower chest wall will be calculated as Dapex(upper) / Dbase(lower)×100(%). The presence of pulmonary problems such as atelectic areas will be determined on the chest radiograph and the change in trunk diameter and depth during thoracic expansion will be monitored.
Measured: 8 week
Secondary outcomes (7)
Philadelphia Children's Hospital Infant Test of Neuromuscular Disorders (CHOP-INTEND)
Philadelphia Children's Hospital Infant Test for Neuromuscular Disorders (CHOP-INTEND) will be used to evaluate motor functions. The CHOP INTEND is a functional scale that has been shown to reliably assess motor function in patients with infancy-onset Type I SMA and other neuromuscular disorders. The development of the scale is based on the natural history of motor function progression for infants with Type I SMA. The test contains 16 items that provide information on muscle strength and function, gravity eliminated, gravity assisted, and antigravity. Items are ranked from easy to difficult, with the least tolerated items being tested last.
- Scoring: rated from 0 (no response) to 4 (complete response). The maximum score is 64.
- Application time: It can be completed in 15-40 minutes.
- Equipment: mat, rattle, plush toy, toy phone.
Measured: 8 week
Hammersmith Extended Functional Motor Scale (HFMSE)
Hammersmith Functional Motor Scale Extended Version (HFMSE) will be used to evaluate motor functions. The HFMSE test consists of 33 items in which movements such as sitting, rolling in the supine position, raising the head in the lying position, standing up, kneeling, standing and stepping, jumping, and climbing stairs are scored. Each item is evaluated on a scoring system with 2 points for "can do without support", 1 point for "can do with support" and 0 points for "can't".
The scores of all items are summed, the total score ranges from 0 to 66, and a higher score means better motor functions.
Measured: 8 week
World Health Organization Motor Development Scale (WHO Developmental Milestones)
With the World Health Organization Motor Development Scale, 6 different gross motor levels will be evaluated as unsupported sitting, hand-knee crawling, assisted standing, assisted walking, standing alone and walking alone.
Measured: 8 week
Supine Trunk Rotation Angle Test
Chest deformity will be measured using a scoliometer (Basic Economics). The patient will be in the supine position with the head symmetrical. Scoliometer, 2nd-3rd in the upper part of the sternum. it will be located along the chest at the level of the rib (SATR upper) and below the sternum, where the corpus meets the xiphoid process of the sternum (SATR lower).
Measured: 8 week
Pelvic Tilt Test
Pelvic tilt measurement will be made using a scoliometer (Basic Economics) placed at the posterior superior iliac spines in a modified sitting position with supported upper and lower extremities.
Measured: 8 week
Quebec Assistive Technology User Satisfaction Assessment Questionnaire (QUEST)
The Quebec Assistive Technology User Satisfaction Assessment Questionnaire (QUEST) will be used to assess spinal orthosis satisfaction. Since the patients are in childhood, the questionnaire will be filled in by their parents. Interviews will be conducted face to face. Responses are scored on a 5-point Likert scale for satisfaction (1=very dissatisfied and 5=very satisfied). The QUEST questionnaire has 3 points; these are device satisfaction, service satisfaction and total score. Satisfaction defined in the questionnaire is the individual's critical evaluation of the technological device. The individual's expectations, perception, attitude and personal characteristics affect this evaluation. The QUEST questionnaire contains 12 items questioning the satisfaction of the assistive device (8 items) and the service (4 items). At the end of the questionnaire, individuals/parents are asked to select and mark 3 of the 12 items as important.
Measured: 8 week
Respiratory Evaluation
Respiratory type, frequency and oxygen saturation will be examined. Respiratory type; It will be determined whether the patient has thoracic, abdominal, thoracoabdominal breathing or pursed-lip breathing. Respiratory frequency; It will be recorded as the number of respirations taken and exhaled per minute. Although the normal respiratory frequency is 12-20 respiratory rates/minute; <12 respiratory rate/minute is called bradypnea, >12 respiratory rate/minute is called tachypnea. Oxygen saturation measurement will be carried out by attaching the Contec brand CMS60D handheld pulse oximeter device, which is available at our university, to the children's toes before wearing the corset, while the corset is put on and 10 minutes after the corset is put on.
Measured: 8 week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 May 2023
- Study start11 Oct 2023
- Primary completion23 Jul 2024
- Study completion10 Sep 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Spinal Muscular Atrophy Type IStudies of the same condition, open and under way.
- More trials run by Medipol UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Parallel Assignment randomised controlled trial
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- Medipol University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Emre DANSUK, Medipol University
- Investigators
- Emre Dansuk, MSc, Principal investigator, Medipol University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05878418
- Sponsor's protocol ID
- E-10840098-772.02-200
- Status last verified
- Sep 2024
- First submitted
- 9 May 2023
- Last updated
- 19 Sep 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Dansuk E, Van Den Berg ANT, Ata G, Yikilmaz SK, Oktem S. The effect of thoracolumbosacral orthosis on scoliosis progression and chest deformity in children with type 1 spinal muscular atrophy: A randomized controlled trial. PLoS One. 2025 Sep 15;20(9):e0323341. doi: 10.1371/journal.pone.0323341. eCollection 2025.
PubMed 40953000
Study at a glance
From the registry record, last updated by the sponsor on 19 Sep 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Spinal Orthosis on the Development of Scoliosis and Chest Deformity in Type I Spinal Muscular Atrophy
- ClinicalTrials.gov ID
- NCT05878418
- Acronym / sponsor ID
- E-10840098-772.02-200
- Conditions
- Spinal Muscular Atrophy Type I, Scoliosis, Chest Deformities, Spinal Orthosis, Pulmonary Rehabilitation, Exercise
- Keywords
- Spinal Muscular Atrophy Type I, Scoliosis, Chest Deformities, Spinal Orthosis, Pulmonary Rehabilitation, Exercise
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- Medipol UniversityUniversity, hospital or other
- Study start
- 11 Oct 2023 (actual)
- Primary completion
- 23 Jul 2024 (actual)
- Study completion
- 10 Sep 2024 (actual)
- First posted
- 26 May 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Spinal muscular atrophy (SMA) is a serious neuromuscular disease characterized by the degeneration of alpha motor neurons in the spinal cord, resulting in progressive proximal muscle atrophy and denervation. The main problems are posture disorders, scoliosis, pelvic curvature, contracture, hip dislocation, foot and chest deformities. In this study, examining the effectiveness of trunk support used to alleviate the progression of scoliosis in children diagnosed with SMA Type I will contribute to the current literature.In addition to Individualized Trunk Exercises (ITE), Individualized Pulmonary Rehabilitation (IPR) and Chest Care (CC) Programme, the use of thoracolumbosacral spinal orthosis in Type I children will be used for the first time in our country and in the world literature. SMA. Our aim in the project is to examine the effectiveness of this treatment program on the motor functions, scoliosis Cobb angle, pelvic curvature and chest deformity of children with Type I SMA.The project is planned to be carried out with children diagnosed with Type I SMA who are followed up at Medipol Mega University Hospital Pediatric Chest Diseases Polyclinic.In evaluating the development of scoliosis as the primary outcome measure; Radiological evaluation (Cobb Angle) and examination of chest deformity; Lung X-ray (Basal Chest Wall Upper-Lower Ratio Measurement) will be used. As secondary outcome measures, the Children's Hospital of Philadelphia Infant Test for Neuromuscular Disorders and the Hammersmith Functional Motor Scale Expanded were used to assess motor functions and examine the level of motor development; In the World Health Organization Motor Development Scale body posture assessment; Supine Trunk Rotation Angle Test and Pelvic Curvature Test, pulse oximetry to assess oxygenation; In determining the level of satisfaction with orthosis use; Children/families' information will be questioned through the Quebec Assistive Technology User Satisfaction Evaluation Survey and Personal Information Form.The active control group will receive the ITE, IPR and CC program as a home program and once a week in the outpatient clinic for 8 weeks, 7 days a week, once a day, each session being 50-60 minutes. In the ITE-IPR-CC + spine orthosis group, in addition to the control group program, a thoracolumbosacral spine orthosis specially designed for the child will be used every day of the week and 8 hours a day for 8 weeks. Evaluations will be made at baseline and at week 8.
Detailed description
With the increase in scoliosis and scoliosis-related symptoms after increased survival in patients with Type I SMA, the need for physiotherapy applications has become more important than ever (Trenkle, et al., 2021; Mercuri, et al., 2018). The presence of scoliosis significantly affects lung capacity, postural control, functionality and quality of life in patients with Type I SMA. For this reason, it is of great importance to treat these patients in a timely and effective manner. There is no consensus on the type of spinal orthosis and application protocol to be used in patients with SMA (Mercuri, et al., 2018). When the literature was examined, no study was found about the effect of spinal orthosis use on scoliosis and chest deformity in Type I SMA patients.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
- Model description
- Parallel Assignment randomised controlled trial
| Arm | Type | Receives |
|---|---|---|
| Trunk Exercises, Pulmonary Rehabilitation and Pulmonary Care Program + Spinal Orthosis Group | Experimental | Device: Thoracolumbosacral Spinal Orthosis (TLSO), Other: Trunk Exercise (TE), Pulmonary Rehabilitation(PR) and Pulmonary Care (PC)Trunk Exercises, Pulmonary Rehabilitation and Pulmonary Care Program + Toracolumbosacral Spinal Orthosis |
| Trunk Exercises, Pulmonary Rehabilitation and Pulmonary Care Program Group | Active comparator | Other: Trunk Exercise (TE), Pulmonary Rehabilitation(PR) and Pulmonary Care (PC)Trunk Exercises, Pulmonary Rehabilitation and Pulmonary Care Program |
Who may qualify
- Ages
- 2 to 6 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (5 listed)
- 2-6 years old,
- Clinically and genetically diagnosed as Type I SMA,
- Having scoliosis (20-40 Cobb angle),
- Children who have not had any previous spinal surgery,
- Children who have received or continue to receive their medical treatments (nusinersen and onasemnogene abeparvovec).
Key exclusion criteria (7 listed)
- Having acute respiratory failure and/or serious airway infections,
- 24-hour mechanical ventilation dependency,
- Continuing medical treatment in intensive care,
- Having other orthopedic and neurological problems,
- Children of parents who did not agree to participate in the study,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Thoracolumbosacral Spinal Orthosis (TLSO)Also: Pulmonary Rehabilitation, Pulmonary Care, Trunk ExerciseIn the TE, PR, PC + spinal orthosis group, in addition to the control group program, a thoracolumbosacral spinal orthosis (TLSO) designed specifically for the child will be used for 8 hours a day for 8 weeks, every day of the week. | Device | Trunk Exercises, Pulmonary Rehabilitation and Pulmonary Care Program + Spinal Orthosis Group |
| Trunk Exercise (TE), Pulmonary Rehabilitation(PR) and Pulmonary Care (PC)The active control group will receive a TE, PR and PC program in the outpatient clinic once a week for 8 weeks, 7 days a week, once a day, 50-60 minutes per session, for 8 weeks. | Other | Trunk Exercises, Pulmonary Rehabilitation and Pulmonary Care Program + Spinal Orthosis Group, Trunk Exercises, Pulmonary Rehabilitation and Pulmonary Care Program Group |
Primary outcome
Radiological Evaluation (Cobb Angle)
Time frame: 8 week
The presence of scoliosis will initially be evaluated clinically using spinal x-rays. The Cobb angle will be used as a measure of scoliosis progression. If possible, radiological evaluation will be performed in the assisted sitting position without providing sitting balance, if it is difficult to take X-rays in the sitting position, in the supine position. Two images will be obtained, anteroposterior and lateral. The location of scoliosis will be classified as thoracic, thoracolumbar and lumbar. Scoliosis direction will be recorded as right and left. In the case of S-shaped scoliosis, the angle used for assessment will be the highest degree.
Lung X-ray (Basal Chest Wall Upper-Lower Ratio Measurement)
Time frame: 8 week
The anteroposterior view of the chest radiograph taken in the supine position will be used. A perpendicular line will be drawn connecting the spinous processes to the horizontal lines drawn from the inner edge of the rib. The longest line of the 2nd rib (Dapex(upper)) and the 9th rib (Dbase(lower)) will be measured. The percentage ratio of the upper/lower chest wall will be calculated as Dapex(upper) / Dbase(lower)×100(%). The presence of pulmonary problems such as atelectic areas will be determined on the chest radiograph and the change in trunk diameter and depth during thoracic expansion will be monitored.
7 secondary outcomes
Philadelphia Children's Hospital Infant Test of Neuromuscular Disorders (CHOP-INTEND)
Time frame: 8 week
Hammersmith Extended Functional Motor Scale (HFMSE)
Time frame: 8 week
World Health Organization Motor Development Scale (WHO Developmental Milestones)
Time frame: 8 week
Supine Trunk Rotation Angle Test
Time frame: 8 week
Pelvic Tilt Test
Time frame: 8 week
Quebec Assistive Technology User Satisfaction Assessment Questionnaire (QUEST)
Time frame: 8 week
Respiratory Evaluation
Time frame: 8 week
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Sep 2024.
- Derived from this study: PubMed 40953000Dansuk E, Van Den Berg ANT, Ata G, Yikilmaz SK, Oktem S. The effect of thoracolumbosacral orthosis on scoliosis progression and chest deformity in children with type 1 spinal muscular atrophy: A randomized controlled trial. PLoS One. 2025 Sep 15;20(9):e0323341. doi: 10.1371/journal.pone.0323341. eCollection 2025.
- Individual participant dataSharing planned: No
Related trials for Spinal Muscular Atrophy Type I
RecruitingObservational study
A Study of Risdiplam in Participants With Type I and Type II Spinal Muscle Atrophy (SMA)
Spinal Muscle Atrophy
Not yet recruitingEarly Phase 1
SPX-01 Gene Therapy in Pediatric Patients With Spinal Muscular Atrophy Type 1 (RISE)
Spinal Muscular Atrophy (SMA)
RecruitingObservational study
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders, Undiagnosed Disorders
RecruitingPhase 1/2
A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I
Spinal Muscular Atrophy 1
Active, not recruitingPhase 3
Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi
Spinal Muscular Atrophy Type I, Spinal Muscular Atrophy Type II
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Emre Dansuk, MSc principal investigator
Medipol University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Thoracolumbosacral Spinal Orthosis (TLSO) and Trunk Exercise (TE), Pulmonary Rehabilitation(PR) and Pulmonary Care (PC) in people with Spinal Muscular Atrophy Type I and Scoliosis, run by Medipol University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Radiological Evaluation (Cobb Angle) (time frame: 8 week). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05878418, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.